Home Blog Page 466

MRPL Receives Special Innovation Award

0

Mangalore Refinery and Petrochemicals Limited (MRPL) has been honoured with the prestigious Special Award for Innovation. The Centre for High Technology, Ministry of Petroleum and Natural Gas, presented the award.

The award was presented at the 27th Energy Technology Meet held in Bengaluru.

The recognition highlights MRPL’s efforts in ‘First-Principles and Artificial Intelligence Hybrid Applications for Process Efficiency and Reliability Improvement’.

Consistent Innovation

This is the third consecutive year that MRPL has been honoured for its refining innovations. The recognition comes from the government of India, through the Centre for High Technology.

Such repeated recognition underscores the company’s dedication to driving technological advancements in the industry.

The Commitment

Mundkur Shyamprasad Kamath, Managing Director of MRPL, stated, “Team MRPL is honored. We received the innovation award.” This is the third consecutive year we’ve received it under the special category at the Energy Technology Meet.” This is a proud moment.” This achievement reflects MRPL’s commitment to developing innovative solutions to real-world challenges”.

Kamath further credited the creation of an environment by MRPL’s Innovation Hub, where every challenge is approached with the mindset of “why not solve it.”

As reported by thehindubusinessline.com, the culture of innovation and determination has been pivotal in shaping MRPL’s identity. It has guided the company toward even greater success in the future.

Ohmium International to Launch CO2 to Green Methanol Facility

0

Ohmium International, a leader in green hydrogen solutions, has announced a partnership with the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Breathe Applied Sciences, and Spirare Energy to establish India’s first CO2-to-green methanol facility.

The pioneering project will use green hydrogen generated by Ohmium’s Proton Exchange Membrane (PEM) electrolyzers and CO2 captured from the Singareni Thermal Power Plant to produce green methanol.

The Conversion

The process to synthesize green methanol from CO2 emissions was developed by researchers at Breathe Applied Sciences and JNCASR.

Ohmium’s PEM electrolyzers, procured by Spirare Energy, play a crucial role in this process by providing the green hydrogen needed to convert the captured CO2.

Professor Sebastian Peter, Co-founder of Breathe Applied Sciences and project leader highlighted, “Converting CO2 from coal-based thermal power to green methanol can significantly advance decarbonization and sustainability. We are excited to see our research applied and look forward to scaling this technology”.

Industry Collaboration

Suhas Bhasin, CEO of Spirare Energy, emphasized the benefits of partnering with Ohmium. He highlighted the efficiency and cost-effectiveness of their PEM electrolyzer technology. “Ohmium is a trusted partner, and their hyper-modular design streamlines installation and scaling,” Bhasin said.

Arne Ballantine, CEO of Ohmium International, added, “This is our second project together. It is critical, as green methanol can advance India’s energy independence and reduce CO2 emissions.” Building on previous successes, this follow-on project demonstrates our joint commitment to India’s energy future”.

Role in Sustainability

Methanol, commonly used as a fuel and raw material in industrial processes. It produces high levels of greenhouse gases when derived from fossil fuels.

By creating green methanol, Ohmium and its partners are helping to decarbonize the methanol production process. This in turn decreases emissions across sectors, including coal-based thermal power.

Green Hydrogen Ecosystem

Ohmium continues to strengthen its presence in India. It is collaborating with industry giants like NTPC and Tata Projects.

In July 2024, Ohmium inaugurated its Gigafactory in Bangalore, marking a significant milestone in green hydrogen production.

As reported by businesswireindia.com, Ohmium was selected for Tranche II of the Ministry of New and Renewable Energy (MNRE) SIGHT Incentive Program, further demonstrating its commitment to accelerating India’s green hydrogen and sustainable energy ecosystem.

Coal Ministry Receives Strong Industry Response to Coal Gasification Incentive Scheme

0

The ministry of coal (MoC) has received substantial industry support for its Financial Incentive Scheme, aimed at accelerating coal gasification projects and advancing India’s commitment to a sustainable, low-carbon future.

The scheme represents a significant step in India’s energy transition and has garnered enthusiastic participation from key players in the coal sector.

Strong Participation in Technical Proposal Submissions

On November 11, 2024, the coal ministry closed submissions for category I and III proposals, with a total of five proposals received.

Category I saw three submissions from government public sector undertakings (PSUs) or joint ventures of PSUs. The category III had two entries focused on demonstration projects and
small-scale plants.

The technical proposals, opened on November 12, underscored the industry’s growing confidence in coal gasification as a vital component of India’s clean coal strategy.

Coal Gasification: A Key to India’s Clean Coal Transition

Vismita Tej, Additional Secretary at MoC, highlighted the initiative’s importance in transforming India’s coal sector.

Tej expressed optimism about the strong participation, emphasizing that it demonstrates the industry’s increasing commitment to cleaner, more efficient technologies.

She assured that the ministry is committed to working alongside stakeholders and addressing any concerns to ensure the success of this sustainable transition.

Financial Backing and Ambitious Goals for 2030

An investment of ₹8,500 crore backs the scheme. It aligns with India’s larger objective of achieving 100 million tons of coal gasification by 2030.

The initiative aims to utilize India’s domestic coal reserves responsibly, supporting national energy needs and climate goals.

Extension for Private Sector Participation

To encourage broader participation, the ministry has extended the deadline for category II submissions. Private companies and PSUs are targeted by it to January 10, 2025.

As reported by energycentral.com, the extension aims to draw in more stakeholders. It  amplifys the scheme’s momentum and fostering diverse collaboration across the sector.

Arvinder Singh Sahney Appointed CMD of IOCL

0

Arvinder Singh Sahney has been appointed as the Chairman and Managing Director of Indian Oil Corporation Ltd (IOCL), effective immediately.

The Appointments Committee of the Cabinet (ACC) confirmed his appointment, marking a new chapter in his thirty-year career with the state-run oil giant.

Vast Industry Experience

Sahney steps into the role, taking over from V. Satish Kumar, the company’s director of marketing, who had been holding the additional charge as CMD since September 1. Before this elevation, Sahney was in charge of IOCL’s petrochemicals division, a pivotal area for the company’s growth.

According to the government’s announcement, Sahney’s tenure as CMD will last for five years or until his superannuation, whichever comes first.

Technical Expertise

With more than three decades of experience in refining and petrochemicals, Sahney has worked at five of IOCL’s nine refineries.

Among his significant achievements, Sahney played a critical role in the commissioning and optimization of the fifteen MMTPA Paradip refinery, which has greatly enhanced India’s refining capabilities and contributed to the nation’s energy security.

Driving Petrochemical Expansion

Before his current appointment, Sahney led IOCL’s petrochemical division, spearheading strategic initiatives such as the development of the massive Paradip petrochemical complex.

This project aims to solidify Indian Oil’s position in the petrochemicals market, as the company looks to increase its footprint in this fast-growing sector.

Sustainable Development

Arvinder Singh Sahney also chairs Terra Clean Ltd, a subsidiary of IOCL focused on sustainable solutions, reinforcing Indian Oil’s commitment to environmental responsibility.

His leadership comes at a crucial time, as IOCL and other state-run oil companies ramp up their efforts to integrate eco-friendly practices into their operations.

As reported by livemint.com, with this appointment, Sahney brings both expertise and vision to Indian Oil, steering it towards an expanded role in India’s energy and petrochemical landscape.

UPL Corporation and CAC Nantong Forge Agreement for Cyproflanilide Insecticide

0

UPL Corporation Ltd. and CAC Nantong Chemical Co. Ltd. announced a strategic partnership aimed at developing, registering, and commercializing cyproflanilide products across their respective markets.

UPL Corp and CAC Nantong partnership brings together two known players in the global agrochemical industry to introduce a highly effective and innovative solution for pest control.

About Cyproflanilide

A new weapon against pest resistance cyproflanilide is a cutting-edge insecticide designed to combat pest resistance, particularly in challenging pest populations.

It is effective against a wide range of chewing pests in multiple crops, including rice, corn, cotton, soybeans, fruits, and vegetables.

The product stands out for its high efficacy at low application rates, and its ability to control a broad spectrum of pests, including lepidoptera species resistant to traditional insecticides.

Additionally, cyproflanilide works through both contact and ingestion methods, offering versatility in pest management. Farmers can use it in foliar and soil applications, and it can even extend to the public health sector.

Strategic Agreement

Christina Coen, Chief Marketing Officer of UPL Corporation mentioned, “We are thrilled to enter this long-term agreement with CAC Nantong to introduce this revolutionary insecticide to more growers in new markets. This collaboration fits well with our value-added portfolio strategy. It introduces a proprietary active ingredient with a unique mode of action. It highlights our commitment to advancing agricultural innovation and setting new standards in pest management.”

Coen added that adding cyproflanilide to UPL’s global portfolio would enable the company to offer farmers differentiated solutions. These solutions will improve pest management, increase crop yields, and contribute to food security worldwide.

Global Reach

Norman Wu, Global Marketing Head of CAC Nantong’s Crop Protection Business Unit, said, “We are delighted to have reached this important milestone. This achievement is in partnership with UPL Corp.” This collaboration strengthens CAC Nantong’s dedication to scientific and technological development, furthering our long-term commitment to product innovation. Through this partnership, we can accelerate the global application of cyproflanilide, helping growers protect their crops and achieve higher yields. This in turn contributes to global food security”.

Global Launch

Experts expect to classify cyproflanilide as a meta-diamide in the IRAC’s Group 30 list of compounds. The registration process is already underway, with approval expected soon in China.

As reported by prnewswire.com, UPL Corp and CAC Nantong anticipate securing the first wave of registrations. They expect this process to take place in various countries over the next three years. They aim to bring this breakthrough product to markets worldwide.

IOCL to Complete Refinery Expansions by December 2025

0

Indian Oil Corporation Limited (IOCL) is set to complete the expansion of its refineries in Panipat, Gujarat, and Barauni by December 2025.

The expansions, initially slated for earlier completion, faced delays due to the COVID-19 pandemic and the ongoing crisis in Ukraine.

Expansion Projects

The Barauni refinery in Bihar is undergoing a capacity upgrade from six million tons per annum (MMTPA) to 9 MMTPA.

This expansion, estimated at 160 billion rupees ($1.9 billion), has seen a 10% cost overrun.

Similarly, IOC has increased the budget for Panipat’s refinery expansion, raising costs from the initial 330 billion rupees to 362.25 billion rupees.

Increased Capacity

Indian Oil Corporation Limited is expanding its Panipat refinery capacity from fifteen MMTPA to twenty-five MMTPA.

The Gujarat refinery, meanwhile, is increasing from 13.7 MMTPA to eighteen MMTPA, with plans for integration into lube and petrochemical production systems.

The expansions align with the country’s broader goal to boost its refinery capacity to 450 million tons per annum (MTPA), up from the current 249 MTPA, or approximately five million barrels per day.

Unit Shutdowns

To support these upgrades, IOCL plans to temporarily shut down the hydrocracker and certain secondary units at the Gujarat refinery by the fiscal year-end.

Additionally, the gasoline-making unit at the Barauni refinery will undergo revamping. This will take place in the first to second quarters of the upcoming fiscal year.

Revised Timelines

Initially, they expected to complete the Gujarat refinery expansion by mid-2024, but recent setbacks have pushed this date back.

As reported by marketscreener.com, similarly, Panipat’s expansion has also seen delays of over a year. Now, all three refinery upgrades are set to converge for completion by the end of 2025.

BASF to Expand X3D® Catalyst Shaping Capacity in Ludwigshafen

0

BASF announced plans to invest in additional production capacity for its X3D® technology, a groundbreaking additive manufacturing technology for catalysts.

The new facility, set to be operational in 2026, will enable BASF to produce catalysts on an industrial scale, significantly advancing its ability to meet growing customer demand.

Transforming Catalyst Design and Performance

X3D technology is a significant leap forward in the design and production of catalysts. Catalysts made using this technology are not only mechanically robust but also feature an innovative open structure.

This design dramatically reduces the pressure drop across reactors while increasing the surface area, which enhances catalyst performance.

As a result, customers can expect improved reactor output, higher product quality, and reduced energy consumption, all of which contribute to achieving their green transformation goals.

Versatility and Customization

One of the standout advantages of X3D technology is its versatility. It can be applied to a wide range of catalytic materials. It includes both precious and non-precious metal catalysts as well as various carriers.

This flexibility allows BASF Investment to tailor catalysts to specific customer needs by adjusting parameters such as infill patterns, fiber diameters, and orientations, ensuring that every solution is optimized for maximum efficiency.

Innovation and Sustainability

BASF remains committed to leading innovation in the chemical catalysts industry.

Detlef Ruff, Senior Vice President of Process Catalysts at BASF stated, “X3D represents a step-change advancement in catalyst production. We are proud to provide our customers with new opportunities to enhance performance while reducing their carbon footprint”.

The Potential

BASF has already seen significant success with X3D catalysts in commercial plants over several years, achieving impressive results.

Jens Perregaard, Vice President of Custom Catalysts and Innovation at BASF highlighted, “X3D is poised to shape the future of both green and traditional value chains by delivering unparalleled efficiency and faster speed-to-market”.

As per the press release, with this new investment, BASF will continue to position it as a leader in sustainable catalyst solutions, driving both innovation and performance for its customers worldwide.

Clariant Enhances Syngas Catalyst Portfolio for Better Sustainability and Profitability

0

Clariant, a sustainability-focused specialty chemicals company, has successfully introduced its new Plus series syngas catalysts.

Over the last five years, the company has upgraded its syngas catalyst portfolio, launching the ReforMax LDP Plus, ShiftMax 217 Plus, and AmoMax 10 Plus.

Clariant Enhances Syngas Catalyst to build upon the success of their predecessors, offering drop-in solutions designed to improve plant economics and reduce carbon emissions.

Commercial use has already demonstrated highly favorable results, confirming their effectiveness.

Step Toward Decarbonization

Georg Anfang, Vice President of Syngas and Fuels at Clariant Catalysts, emphasized the importance of every action in reducing CO2 emissions.

Anfang said, “The transition to decarbonize the chemical and energy industries is lengthy, and every ton of CO2 savings counts to reach our ultimate goal of net zero. Our syngas Plus catalysts are designed to improve efficiency and sustainability while enabling the deployment of new low-carbon applications like hydrogen and ammonia production,”.

The Plus series represents Clariant’s commitment to advancing the global shift toward sustainable chemicals and fuels.

ReforMax LDP Plus

The ReforMax LDP Plus series, a next-generation catalyst for steam reforming, is used in the production of hydrogen, ammonia, and methanol.

The catalysts feature a unique flower-like 8-hole shape, which reduces pressure drop in reactors by up to 20% compared to previous catalyst shapes.

This innovation improves heat transfer, saves energy, and extends the service life of reformer tubes.

ReforMax 330 LDP Plus was first installed six years ago in a European ammonia plant with a capacity of 1650 mtpd. Since then, it has demonstrated a 20% lower pressure drop than its predecessor.

After six years of operation, the catalyst has stabilized, and thermal imaging of tube wall temperatures shows excellent heat distribution throughout the furnace.

To date, more than 40 production plants around the world have benefitted from the increased productivity enabled by ReforMax LDP Plus.

ShiftMax 217 Plus

The ShiftMax 217 Plus, a low-temperature water gas shift catalyst, offers significantly improved selectivity while maintaining the high activity and stability of its predecessor.

This enhancement reduces methanol formation, a harmful by-product and regulated volatile organic compound (VOC).

As a result, ammonia producers experience higher yields with lower energy consumption.

For example, a European ammonia plant that installed ShiftMax 217 Plus two years ago has seen methanol formation decrease by more than 50%.

This reduction ensures compliance with VOC limits and translates into significant cost savings over the catalyst’s six-year expected lifetime.

AmoMax 10 Plus

The AmoMax 10 Plus is Clariant’s new wustite catalyst for ammonia synthesis, building on the proven performance of the AmoMax 10.

With an improved promoter set, this catalyst offers higher activity and greater robustness against catalyst poisons, as well as faster startups.

Clariant Enhances Syngas Catalyst to enable higher per-pass conversion and lower loop pressure, improving both ammonia production and energy efficiency.

At a European ammonia plant since 2021, the AmoMax 10 Plus has delivered a 24% increase in relative activity compared to the previous generation, enhancing overall plant efficiency.

Comprehensive Solutions

Together, the ReforMax LDP Plus, ShiftMax 217 Plus, and AmoMax 10 Plus catalysts offer a comprehensive solution to improve performance and sustainability across the syngas value chain—spanning reforming, water gas shift, and synthesis.

As per the press release, with rising energy costs and the urgent need to reduce carbon emissions, each improvement in plant operation is a valuable contribution to both the bottom line and the environment.

Seventeenth Edition of CPHI & PMEC India to Showcase Pharma Progress

0

The 17th edition of CPHI & PMEC India, organized by Informa Markets in India, is set to take place from November 26-28, 2024, at the India Expo Centre in Greater Noida, Delhi-NCR.

Known as a comprehensive destination for innovative and cost-effective solutions, 17th edition of CPHI & PMEC expo will focus on modernization, sustainability, and technological advancements in India’s thriving pharmaceutical industry.

Growth Trajectory

India’s pharmaceutical industry is expanding rapidly. It is expected to reach $65 billion by the end of 2024, with projections doubling to $130 billion by 2030.

The CPHI & PMEC India Expo is a testament to this growth, gathering over 2,000 exhibitors and fostering connections between global and domestic stakeholders.

This year’s participants include industry leaders from around the world, with representatives from the USA, UAE, South Korea, Japan, Italy, and other countries.

Marketplace for Innovation

The expo will serve as a vital marketplace, bringing together pharmaceutical executives, buyers, hospital administrators, and government representatives.

Renowned exhibitors like Dr. Reddy’s Laboratories Ltd, Biocon Ltd, Glenmark Lifesciences Ltd, Morepen Laboratories Ltd, and Merck Life Science Pvt. Ltd. will be showcasing their latest developments in pharmaceuticals. These companies will present their innovations in pharmaceuticals.

PMEC exhibitors, including ACG, Accupack Engineering, and Ace Technologies, will present
cutting-edge equipment for pharmaceutical manufacturing, highlighting innovations in machinery and technology.

Industry Support

The event enjoys the support of key industry associations like CIPI, FOPE, IPEC India, and Pharmexcil. This reinforces its reputation as a premier gathering for the pharmaceutical industry.

Yogesh Mudras, Managing Director, Informa Markets in India stated, “India’s pharmaceutical sector, ranking third globally by production volume. It is a leader in delivering high-quality, affordable medicines. The Ministry’s SPI initiative backs our industry, providing Rs. 500 crore ($60.9 million) to strengthen productivity, quality, and sustainability across pharma clusters and MSMEs. Over the years, CPHI & P-MEC India has grown from a trade show into a global platform for business and industry insights”.

Knowledge Exchange

The CPHI & PMEC India Expo will feature The Pharma Connect Congress. This two-day event will spotlight key topics. These include “Continuous Innovation and Agile Manufacturing for Next-Generation Therapeutics.” They also cover “India as the Pharmacy of the World with Cost-Effective Generics and Biosimilars.”

Other discussions will tackle challenges in digital transformation, complexities in biosimilar manufacturing, and advances in research on biosimilars.

Additionally, the Pharma Leaders Roundtable will provide a closed-door forum for senior industry leaders. They will discuss innovation, unmet clinical needs, and strategic solutions.

The Women in Pharma Conference will address diversity and inclusion, focusing on enhancing the role of women in the industry.

As per the press release, celebrating the achievements of pharmaceutical brands, the 10th edition of the India Pharma Awards will honour exceptional contributions to the sector.

CuraTeQ Biologics Gains EMA GMP Certification for Biosimilars Facility

0

CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, has secured a Good Manufacturing Practice (GMP) certificate of compliance from the European Medicines Agency (EMA) for its biosimilars manufacturing facility.

The certification follows an EMA inspection conducted from April 8–12, 2024, marking a significant advancement for CuraTeQ in its efforts to provide high-quality biosimilars worldwide.

Comprehensive GMP Inspection

During the inspection, EMA representatives evaluated multiple aspects of CuraTeQ’s facility, including its mammalian and microbial drug substance manufacturing sections.

Additionally, they assessed the facility’s capabilities in the filling of prefilled syringes and vials, packaging processes, as well as its quality control testing and release laboratories.

The successful completion of these evaluations led to the certification.

European Market Approvals

Satakarni Makkapati, Director of Aurobindo Pharma and CEO of Biologics, Vaccines, and Peptides mentioned, “The EU GMP certification marks a significant step in CuraTeQ’s commitment to manufacturing high-quality biosimilars for patients worldwide.”

He noted that the certification will expedite the review process for three biosimilars currently under assessment by the EMA. He also mentioned that potential approval is expected in the coming two to five months.

Expanding Biosimilars Portfolio

Aurobindo Pharma’s Vice-Chairman and Managing Director, K. Nithyananda Reddy, highlighted the company’s robust portfolio of biosimilars under development. He stated, “Our portfolio includes fourteen biosimilars across oncology and immunology. Our goal is to meet patient needs globally.”

Thehindubusinessline.com reported that with the EU GMP certification in hand, CuraTeQ Biologics can advance its products in the European market. It reflects Aurobindo Pharma’s ongoing commitment to innovative and accessible biosimilar therapies.

Advertisement

Newsletter

Subscribe to our FREE Newsletter & Stay Updated

Advertisement